The cancer burden in the United Kingdom in 2007 due to radiotherapy

International Journal of Cancer

Volumn 129, Issue 12, 2011, Pages 2885-2893

  Maddams, Jacob ^a   Parkin, D Maxwell ^b   Darby, Sarah C ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

attributable fraction; radiotherapy; second cancers; UK

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVOR; COLORECTAL CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MOUTH CANCER; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PHARYNX CANCER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RADIATION INDUCED NEOPLASM; SECOND CANCER; STOMACH CANCER; TESTIS CANCER; UNITED KINGDOM; UTERINE CERVIX CANCER; UTERUS CANCER; ADULT; BREAST TUMOR; MIDDLE AGED; NEOPLASM; RADIOTHERAPY; RISK; STATISTICS; SURVIVOR; TIME;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RISK; SURVIVORS; TIME FACTORS;

EID: 83255165760     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26240     Document Type: Article

References (21)

1. Maddams J, Brewster D, Gavin A, Steward J, Elliott J, Utley M, Møller H,. Cancer prevalence in the United Kingdom: Estimates for 2008. Br J Cancer 2009; 101: 541-7.
2. Watson SJ, Jones AL, Oatway WB, Hughes JS,. Ionising radiation exposure of the UK population: 2005 Review (HPA-RPD-001): Health Protection Agency, Centre for Radiation, Chemical and Environmental Hazards, 2005. Retrieved 15/11/2010, from.
3. Hughes JS, Watson SJ, Jones AL, Oatway WB,. Review of the radiation exposure of the UK population. J Radiol Protect 2005; 25: 493.
4. Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF, Jr,. New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. ed., vol. NIH Publ. No. 05-5302. Bethesda, MD: National Cancer Institute, 2006.
5. Statistics on the most commonly diagnosed types of cancer in the UK: Cancer Research UK, 2010. Retrieved 11/11/2010, from.
6. Berrington de Gonzalez A, Curtis RE, Gilbert E, Berg CD, Smith SA, Stovall M, Ron E,. Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 2010; 102: 220-6.
7. Health risks from exposure to low levels of ionizing radiation: BEIR VII-Phase 2. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. National Research Council Of The National Academies. The National Academies Press, Washington, DC, 2006.
8. Hall EJ,. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006; 65: 1-7.
9. Williams MV, Drinkwater KJ,. Radiotherapy in England in 2007: modelled demand and audited activity. Clin Oncol (R Coll Radiol) 2009; 21: 575-90.
10. One Year Cancer Survival Trends, England, 1985-2004: National Cancer Intelligence Network, 2008. Retrieved 11/11/2010, from.
11. Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Galichet L, Cogliano V, on behalf of the WHO International Agency for Research on Cancer Monograph Working Group A review of human carcinogens-Part A: pharmaceuticals. Lancet Oncol 2009; 10: 13-14.
12. Curtis RE, Boice JD Jr, Stovall M, Bernstein L, Greenberg RS, Flannery JT, Schwartz AG, Weyer P, Moloney WC, Hoover RN,. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl J Med 1992; 326: 1745-51.
13. Smith RE, Bryant J, DeCillis A, Anderson S; National Surgical Adjuvant Breast and Bowel Project Experience,. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol 2003; 21: 1195-204. (Pubitemid 46894010)
14. Praga C, Bergh J, Bliss J, Bonneterre J, Cesana B, Coombes RC, Fargeot P, Folin A, Fumoleau P, Giuliani R, Kerbrat P, Hery M, Nilsson J, et al. Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide. J Clin Oncol 2005; 23: 4179-91. (Pubitemid 46211324)
15. Fisher B, Rockette H, Fisher ER, Wickerham DL, Redmond C, Brown A,. Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience. J Clin Oncol 1985; 3: 1640-58. (Pubitemid 16199216)
16. Effects of Ionizing Radiation. United Nations Scientific Committee on the Effects of Atomic Radiation. UNSCEAR 2006 Report to the General Assembly, with scientific annexes. Volume 1. United Nations, New York, 2008.
17. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-106. (Pubitemid 41797643)
18. Johnson C, Peace S, Adamo P, April A, Percy-Laurry A, Edwards BK,. The 2007 Multiple Primary and Histology Coding Rules: National Cancer Institute, Surveillance Epidemiology and End Results Program, 2007. Retrieved 11/11/2010, from.
19. Gray A, Read S, McGale P, Darby S,. Lung cancer deaths from indoor radon and the cost effectiveness and potential of policies to reduce them. BMJ 2009; 338: a3110.
20. Berrington de Gonzalez A, Darby S,. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet 2004; 363: 345-51. (Pubitemid 38169539)
21. Darby SC, Cutter DJ, Boerma M, Constine LS, Fajardo LF, Kodama K, Mabuchi K, Marks LB, Mettler FA, Pierce LJ, Trott KR, Yeh ET, et al. Radiation-related heart disease: current knowledge and future prospects. Int J Radiat Oncol Biol Phys 2010; 76: 656-65.